durvalumab,pembrolizumab,cisplatin,gemcitabine
merck,astrazeneca
['topaz-1', 'key,note,966', ' gem ', 'kn966']
keynote-966 and topaz-1 are so similar: mos: kn966: 12.7 vs 10.9 mos, hr: 0.83
t1: 12.8 vs 11.5 mos, hr: 0.80 orr:
kn966: 29% vs. 28%
t1: 27% vs 19% key takeaways: anti-pd-1 is weakly effective in btcs. continue gem in maintenance #aacr2023 
GI #Oncologist @ClevelandClinic | @USNews contributor | Tweets my own